These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 33225396)

  • 41. Obesity, glucose intolerance, advanced age, and lymphocytopenia are independent risk factors for oxygen requirement in Japanese patients with Coronavirus disease 2019 (COVID-19).
    Okauchi Y; Matsuno K; Nishida T; Sawada K; Kawasaki A; Ito N; Morimura O; Otani Y; Yokoe M; Abe K; Iwahashi H
    Endocr J; 2021 Jul; 68(7):849-856. PubMed ID: 33762519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study.
    Ao Z; Li Y; Wei J; Jiang J; Wang X; Zhang P; Liu Y; Yu H; Zhu L; Wang X; Hu Q; Duan J; Hu W; Zhang X; Wu G; Guo S
    Clin Exp Med; 2021 Aug; 21(3):361-367. PubMed ID: 33543353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.
    Chen Y; Chen L; Deng Q; Zhang G; Wu K; Ni L; Yang Y; Liu B; Wang W; Wei C; Yang J; Ye G; Cheng Z
    J Med Virol; 2020 Jul; 92(7):833-840. PubMed ID: 32243607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer Patients.
    Tremblay D; Seah C; Schneider T; Bhalla S; Feld J; Naymagon L; Wang B; Patel V; Jun T; Jandl T; Rahman F; Liu STH; Aberg JA; Bouvier N;
    Cancer Med; 2020 Nov; 9(22):8571-8578. PubMed ID: 32945149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19.
    Hu X; Xing Y; Jia J; Ni W; Liang J; Zhao D; Song X; Gao R; Jiang F
    Sci Total Environ; 2020 Aug; 728():138812. PubMed ID: 32335406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.
    Wu P; Duan F; Luo C; Liu Q; Qu X; Liang L; Wu K
    JAMA Ophthalmol; 2020 May; 138(5):575-578. PubMed ID: 32232433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus.
    Zhou Y; Zhang Z; Tian J; Xiong S
    Ann Palliat Med; 2020 Mar; 9(2):428-436. PubMed ID: 32233642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical characteristics of 16 patients with fecal severe acute respiratory syndrome coronavirus 2 nucleic acid-positive.
    Zhou Y; Xiao Z; Chen D; Guan J; Zhou Z; Zhang H; Zhou H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):560-564. PubMed ID: 32879107
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study.
    Li Y; Li M; Wang M; Zhou Y; Chang J; Xian Y; Wang D; Mao L; Jin H; Hu B
    Stroke Vasc Neurol; 2020 Sep; 5(3):279-284. PubMed ID: 32616524
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute Kidney Injury in COVID-19 Patients: An Inner City Hospital Experience and Policy Implications.
    Zahid U; Ramachandran P; Spitalewitz S; Alasadi L; Chakraborti A; Azhar M; Mikhalina G; Sherazi A; Narh JT; Khattar P; Bedi P
    Am J Nephrol; 2020; 51(10):786-796. PubMed ID: 33011717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cancer inpatients with COVID-19: A report from the Brazilian National Cancer Institute.
    de Melo AC; Thuler LCS; da Silva JL; de Albuquerque LZ; Pecego AC; Rodrigues LOR; da Conceição MS; Garrido MM; Quintella Mendes GL; Mendes Pereira ACP; Soares MA; Viola JPB;
    PLoS One; 2020; 15(10):e0241261. PubMed ID: 33104715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of the COVID-19 epidemic at a high-volume facility in gynecological oncology in Tokyo, Japan: a single-center experience.
    Nogami Y; Kobayashi Y; Tsuji K; Yokota M; Nishio H; Nakamura M; Yamagami W; Morisada T; Tominaga E; Banno K; Aoki D
    J Ovarian Res; 2020 Sep; 13(1):105. PubMed ID: 32917254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
    Ghati N; Roy A; Bhatnagar S; Bhati S; Bhushan S; Mahendran M; Thakur A; Tiwari P; Dwivedi T; Mani K; Gupta R; Mohan A; Garg R; Saxena A; Guleria R; Deepti S
    Trials; 2020 Oct; 21(1):902. PubMed ID: 33126910
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison and clinical characteristics of COVID-19 between January and February 2020 in Wuhan, China.
    Yang R; Wei J; Hu W; Xiong J; Liu M; Hu K
    Ann Palliat Med; 2021 Apr; 10(4):4201-4213. PubMed ID: 33832296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiparametric correlation of laboratory biomarkers to multiorgan failure outcome in hospitalized COVID-19 patients: a retrospective observational study.
    Ballini A; Cantore S; Serretiello E; Troiano G; Smimmo A; Dioguardi M; Spirito F; Sasso FC; De Vito D; Lo Muzio L; Di Domenico M
    Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8962-8974. PubMed ID: 37782206
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.
    van Marcke C; Honoré N; van der Elst A; Beyaert S; Derouane F; Dumont C; Aboubakar Nana F; Baurain JF; Borbath I; Collard P; Cornélis F; De Cuyper A; Duhoux FP; Filleul B; Galot R; Gizzi M; Mazzeo F; Pieters T; Seront E; Sinapi I; Van den Eynde M; Whenham N; Yombi JC; Scohy A; van Maanen A; Machiels JP
    BMC Cancer; 2021 May; 21(1):578. PubMed ID: 34016086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China.
    Zhang N; Wang C; Zhu F; Mao H; Bai P; Chen LL; Zeng T; Peng MM; Qiu KL; Wang Y; Yu M; Xu S; Zhao J; Li N; Zhou M
    Front Endocrinol (Lausanne); 2020; 11():571037. PubMed ID: 33071977
    [No Abstract]   [Full Text] [Related]  

  • 60. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.